Our research displayed that ELF4 was a reliable predictor of an unfavorable prognosis in glioma and correlated with clinicopathological characteristics such as IDH mutation status, 1p19q codeletion, and WHO grade, through a comprehensive analysis. This evidence concerns the gene IDH1 and central nervous system cancer.